ArticleBMC cancer2025

Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy - a pilot study.

Lea Pöschmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.